Two diluents dominate the peptide reconstitution literature: sterile water for injection and bacteriostatic water for injection (BAC water). They are chemically and functionally different in one specific but important way, and the choice between them influences vial-life, contamination risk, and compatibility with specific peptides.

What each diluent is

  • Sterile water for injection (SWFI) — sterile water, free of preservatives, packaged as a single-use diluent in ampoules or vials. Used in hospital pharmacy compounding for single-dose reconstitution where the resulting solution is drawn immediately and any remaining volume is discarded.
  • Bacteriostatic water for injection (BAC water) — sterile water containing 0.9% benzyl alcohol as an antimicrobial preservative, packaged in multi-dose vials. The preservative inhibits microbial growth after the seal is first pierced, permitting multi-use across the vial’s labelled shelf life.

Both are USP-grade injectable diluents. Neither contains buffer salts, electrolytes, or other tonicity agents.

Why BAC water is standard for lyophilised peptides

Research peptide vials are typically reconstituted and then drawn from repeatedly over 14–30 days. Every needle insertion into the vial stopper is a potential contamination event; if the diluent is not preservative-containing, that risk is significant across the working life of the vial.

The 0.9% benzyl alcohol in BAC water is well-characterised as inhibiting growth of the bacteria most likely to be introduced by needle penetration. That is the reason BAC water is described across the peptide-research literature as the default diluent for multi-use lyophilised peptide vials.

When BAC water is a poor choice

Several peptides in the research literature are described as incompatible with benzyl alcohol or with the slightly acidic pH of BAC water. For those peptides, sterile water for injection or 0.9% saline is preferred:

  • GHK-Cu — the copper coordination sphere of the tripeptide-copper complex can be disturbed by benzyl alcohol; sterile water or saline is preferred and the reconstituted solution has a shorter useful life. See the GHK-Cu profile.
  • Acidified peptides shipped as HCl salts — some peptides are formulated with specific counter-ions that assume a particular reconstitution pH. Check the supplier’s data sheet before defaulting to BAC water.
  • Peptides intended for oral or nasal administration in populations sensitive to benzyl alcohol — for example, formulations intended for use in neonatal research (a historical safety flag) or in individuals with a known benzyl-alcohol sensitivity.

Storage implications

A BAC-reconstituted lyophilised peptide vial is typically refrigerated at 2–8 °C and reported as useful for approximately 30 days, with individual peptide-supplier data sheets sometimes extending that to 60 or 90 days. A sterile-water-reconstituted vial is generally treated as usable for a shorter interval — commonly one to two weeks refrigerated — because it lacks the preservative safeguard.

The relative durability difference is the main practical reason to prefer BAC water when the peptide chemistry does not contraindicate it.

Handling in the research literature

Reconstitution technique is the same for either diluent: BAC water or sterile water is drawn into a 3 mL syringe, injected slowly down the inner glass wall of the peptide vial to avoid mechanical stress on the lyophilised peptide cake, and swirled — never shaken — until dissolution is complete. See the reconstitution guide for the full procedure.

Reminder

Nothing in this guide constitutes medical advice or a recommendation to administer any peptide. This is a scientific-reference description of a technique described in the research literature. See our disclaimer.